Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.24 -0.06 (-4.58%)
As of: Sep 29, 2026 · 3:50 PM EDT

Zhengye Biotechnology Holding (ZYBT) Operating Leases (2025)

Updated

Zhengye Biotechnology Holding's Operating Leases was $46,105 in the quarter ended Dec 31, 2025.

Analysis

Zhengye Biotechnology Holding (ZYBT) Operating Leases (2025) Analysis & Trends

As of Dec 31, 2025, Operating Leases at Zhengye Biotechnology Holding came in at $47,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Zhengye Biotechnology Holding 61.61 Mn 48.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46,104.58
API Access

Zhengye Biotechnology Holding Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ZYBT&period=max&api_key=YOUR_API_KEY